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XCESS body fat is a cause of cardiovascular
diseases, several important cancers, and nu-
merous other medical conditions
 
1
 
 and is a
growing problem in many countries. In the United
States, for example, the age-adjusted prevalence of
obesity increased by approximately 30 percent from
1980 to 1994.
 
2
 
 In this review we consider the assess-
ment of body fat and the definition of a healthy
body weight for an adult. We also discuss how clini-
cians can use this information in caring for patients.
Because overt obesity has undisputed adverse conse-
quences for health, our focus is on lesser degrees of
adiposity, the consequences of which have been
more controversial.
 
ASSESSMENT OF BODY FAT
 
The measurement of body fat, which is composed
mainly of adipose in the form of triglyceride, repre-
sents a challenge to researchers and clinicians. The
main stores of fat are subcutaneous and intraabdom-
inal, and considerable amounts of fat can also reside
within muscles, particularly in elderly persons. Be-
cause fat is diffuse and inaccessible, it is impossible
to measure total adipose directly. Traditionally, the
gold standard for estimating body fat has been hy-
drodensitometry (underwater weighing), which is
based on the principle that fat tissue is less dense
than muscle and bone. Dual-energy x-ray absorpti-
ometry is now replacing densitometry as a standard
because of its high precision and its simplicity for
the subject. Both of these methods are used primar-
ily for research purposes and are not available for
E
 
routine clinical care, but they can be used to validate
other methods of measuring body fat.
In clinical practice and in large epidemiologic
studies, body fat is most commonly estimated by us-
ing a formula that combines weight and height. The
underlying assumption is that most of the variation
in weight for persons of the same height is due to fat
mass. The formula used most frequently in epidemi-
ologic studies is the body-mass index, also called the
Quetelet index, which is the weight in kilograms di-
vided by the square of the height in meters. In the
19th century, Quetelet observed empirically that in
adults this index is minimally correlated with height
and thus provides an appropriate measure of weight
adjusted for height.
 
3
 
 Among middle-aged adults,
body-mass index is strongly correlated with fat mass
measured densitometrically and adjusted for height
(r is approximately 0.9 for both men and women);
other indexes based on weight and height do not ap-
pear to be superior.
 
4,5
 
Measurements of weight and height, even those
reported by subjects themselves,
 
5
 
 are highly accurate
and do not contribute importantly to errors in assess-
ing body-mass index. The principal limitation of the
body-mass index as a measure of body fat is that it
does not distinguish fat mass from lean mass. Al-
though direct evidence is lacking, body-mass index is
probably a less valid measure of body fatness in older
adults in whom differential loss of lean mass contrib-
utes increasingly to variation in weight. The body-
mass index has proved useful for epidemiologic
research, but many physicians and patients find it dif-
ficult to interpret. Therefore, the values are often back-
translated to weights for specified heights and pre-
sented in tables that give weight guidelines (Table 1).
Other methods used in assessing fatness are body
circumferences (most commonly waist and hip), skin-
fold thicknesses, and bioimpedance. The measure-
ment of body circumference has received attention
because of the interest in excess visceral (intraab-
dominal) fat — independent of total adiposity — as
a potential risk factor for chronic diseases. Waist cir-
cumference and the ratio of waist circumference to
hip circumference have both been used for this pur-
pose, but neither provides a precise estimate of vis-
ceral fat.
 
6,7
 
 Furthermore, their ability to predict dis-
ease may result, in part, from the information they
provide on overall fatness, not just visceral fat. There
is usually no doubt that a large or increasing abdom-
inal circumference is due to excess fat, after ascites has
been ruled out.
Measurements of skin-fold thickness can provide
a reasonable assessment of body fat, especially if tak-
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en at multiple sites, and they provide additional in-
formation on the location of the fat. However, these
measurements are subject to considerable variation
between observers, do not provide information on
abdominal and intramuscular fat, and in general are
not superior to simple measurements of weight and
height.
 
4,5
 
 Thus, measurements of skin-fold thickness
are most useful to specialists in body composition
and for research.
The measurement of bioimpedance is based on the
principle that lean mass, because it is primarily an
electrolyte solution, conducts current better than fat
mass. Thus, a measurement of the resistance to a weak
current (impedance) applied across the extremities,
when combined with height and weight and an em-
pirically derived equation, provides an estimate of
body fat. Devices to measure bioimpedance are simple
and moderately priced and impose a minimal bur-
den on patients, but they do not measure fat better
or predict biologic outcomes more accurately than
simple anthropometric measurements.
Because many of the adverse effects of excess body
fat on cardiovascular risk factors and disease may re-
sult from increased resistance to insulin, biochemical
measurements that reflect insulin resistance may be
useful as indicators of fat mass. Such measurements
could include fasting levels of insulin and triglycer-
ides and levels of high-density lipoprotein cholesterol.
Plasma leptin levels are strongly correlated with fat
mass,
 
8
 
 but these measures have not been evaluated
adequately for the assessment of adiposity.
 
DEFINITION OF HEALTHY WEIGHT
 
Traditionally, the criterion for setting weight guide-
lines has been the range of weights that correspond
to the lowest mortality. Using mortality as an end
point is simple, reliable, and intuitively appealing.
However, basing guidelines on total mortality rates
is fraught with methodologic problems.
Reverse causation is the most serious problem as-
sociated with using total mortality as an outcome;
people frequently lose weight as a result of an illness
that is ultimately fatal, a situation that creates the ap-
pearance of higher mortality among those with lower
weights. Conditions that cause weight loss may re-
main undiagnosed for several months or years, as
could be the case for occult neoplasms, chronic lung
or cardiac disease, alcoholism, or depression. Several
strategies can be used to minimize the effect of re-
verse causation. Subjects with diagnoses that might
affect weight and subjects who report recent weight
loss, such as during the previous five years, can be
excluded from a prospective study. Deaths that occur
during the first several years of follow-up — possibly
as a result of conditions that caused lower weights at
base line — can also be excluded. Although valuable,
these strategies do not provide a perfect solution
to the problem of reverse causation, because some
chronic conditions may cause weight loss many years
before death occurs. If the period for excluding deaths
or the total follow-up is too long, many subjects will
have substantial changes in weight that are not the
result of underlying disease, and weight status dur-
ing the later years of the study will be misclassified.
Thus, some compromise must be reached: at least
the first several years of follow-up should be exclud-
ed, and follow-up should probably not continue for
more than 10 or 15 years without some updating of
weight status. Analyses that vary the censoring peri-
od and follow-up time can be used to determine
how sensitive the findings are to these decisions.
A second major concern is that confounding fac-
tors may distort the association between body weight
and mortality. Smoking is particularly important, be-
cause smokers tend to weigh less and to have much
higher mortality rates than nonsmokers. As with ill-
 
*Data are from the Department of Agriculture
and Department of Health and Human Services.
 
1
 
These guidelines represent a body-mass index of 19
to 25. The body-mass index can be calculated as
[weight (lb) ¬ 703] ÷ [height (in.)
 
2
 
]. To convert
values for height to centimeters, multiply the height
in inches by 2.54. To convert values for weight to
kilograms, multiply by 0.45. Weight gains of more
than 10 lb after 21 years of age should be avoided,
even if weight remains within the healthy range.
†The subject does not wear shoes when height is
measured.
‡The subject is unclothed when weight is measured.
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4'10"
4'11"
5'0"
5'1"
5'2"
5'3"
5'4"
5'5"
5'6"
5'7"
5'8"
5'9"
5'10"
5'11"
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101–132
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114–150
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129–169
132–174
136–179
140–184
144–189
148–195
152–200
156–205
160–211
164–216
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ness, smoking will make leaner persons appear to be
at elevated risk. Many large studies, including those
conducted by the Metropolitan Life Insurance Com-
pany that were used for many years to set weight
standards,
 
9
 
 did not include data on smoking and thus
overstated desirable weights. Even if data on smoking
are available, simple statistical adjustments for smok-
ing are not entirely satisfactory, because nuances such
as depth of inhalation and genetic susceptibility,
which cannot be accounted for, could influence the
effect of smoking on both weight and mortality.
The most satisfactory way to deal with smoking is
to restrict the analysis to subjects who have never
smoked. Unfortunately, many studies have been too
small to have adequate statistical power when the
analysis is limited to those who have never smoked,
in part because death rates are lower in this group.
Other factors that could confound the association
between body weight and mortality are the presence
or absence of alcoholism, the composition of the diet,
and physical activity. Adjustment for physical activity
may not be appropriate, because activity is an impor-
tant determinant of body weight. 
A third problem in some earlier analyses of studies
of weight and mortality is that the physiologic effects
of excess fatness, such as hypertension, diabetes, and
dyslipidemia, were controlled for statistically, thus
artificially removing some of the effects of being
overweight.
The leanest group in a population is a mix of smok-
ers, persons who have lost weight as a result of un-
derlying disease, and persons who have maintained
a lean weight by balancing physical activity and ca-
loric intake. Thus, in analyses adjusted only for age,
the relation between body weight and mortality is
typically 
 
U
 
-shaped, with increased death rates among
both the leanest and the heaviest persons. However,
because of the potential for bias, these results should
not be accepted as evidence that low weight is harm-
ful. Also, in analyses controlled only for age, the range
of weights associated with the lowest mortality tends
to increase with age. However, this finding may re-
flect the burden of chronic illness that accumulates
with age, which would result in the low-weight
groups gaining a greater percentage of persons at
higher risk of dying. Such observations, based on
data biased by reverse causation and inadequate con-
trol for smoking, were the foundation for the 1990
U.S. guidelines for weight, in which the range of
healthy weights increased with age from a body-
mass-index range of 19 to 25 before 35 years of age
to 21 to 27 thereafter.
 
10
 
 These guidelines implied that
a weight gain of 4.5 to 6.8 kg (10 to 15 lb) at 35
years of age was desirable and that about 5 percent
of middle-aged men and 17 percent of middle-aged
women in the United States risked having poor health
by being underweight.
 
11
 
Unfortunately, few studies have tried simultane-
ously to minimize reverse causation, account for cig-
arette smoking, and not adjust statistically for the
physiologic effects of excess body fat. A review of
the 25 major studies published up to 1986
 
12
 
 found
that not one study met these three criteria. In a recent
meta-analysis,
 
13
 
 only two studies (both of men)
 
14,15
 
analyzed data on persons who had never smoked
and also attempted to account for reverse causation.
One of these studies
 
14
 
 included only 13 deaths;
in the other, mortality rates among nonsmokers in-
creased linearly with greater weight.
 
15
 
 Among wom-
en in the Nurses’ Health Study, the typical 
 
U
 
-shaped
relation between body-mass index and mortality was
found in the overall age-adjusted analysis, but the re-
lation became a simple positive one after reverse cau-
sation was accounted for and the analysis was limited
to persons who had never smoked.
 
16
 
 In the most pow-
erful analysis to date, Stevens et al.
 
17
 
 studied, over a
10-year period, mortality rates among men and
women in the large American Cancer Society cohort
who had never smoked. After early deaths were elim-
inated, mortality increased linearly with increasing
body-mass index from very lean to clearly obese at
all ages up to 75 years; the association was weaker at
older ages. For persons younger than 75, total mor-
tality rates were 8 to 35 percent higher among those
with body-mass indexes of 25 to 26.9 and 18 to 40
percent higher among those with body-mass indexes
of 27.0 to 28.9 than among persons with body-mass
indexes of 19 to 21.9 (Fig. 1).
Although total mortality should be one criterion
for weight guidelines, the incidence of disease should
also be considered. Artifacts resulting from reverse
causation are much less of a problem in studies of
the incidence of disease than in studies of death. Al-
so, conditions such as coronary heart disease, stroke,
diabetes, cancer, and osteoarthritis contribute greatly
to suffering even if they do not result in death. Fur-
thermore, guidelines should be based on something
more than statistical associations between weight
and death. For leanness to cause excess mortality, it
should cause either an increased incidence of one or
more common diseases or a higher case fatality rate.
The lack of evidence for such effects or of a biologic
mechanism to explain an elevated risk of death
among lean persons should have aroused concern in
the early studies that the excess mortality in that
group may have been due to artifact.
The relation between body-mass index and the
incidence of several common conditions caused by
excess body fat — specifically, type 2 diabetes, hyper-
tension, coronary heart disease, and cholelithiasis —
in women and men is presented in Figure 2. The re-
lations in the range of body-mass indexes less than 30
appear monotonic and approximately linear. In wom-
en with a body-mass index of 26, the risk of coronary
heart disease was about twice the risk in women
with a body-mass index of less than 21; the risk in
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men with a body-mass index of 26 was about 1.5
times the risk in men with a body-mass index of less
than 21. For the same comparison, the risk of dia-
betes was four times as high in the men and eight
times as high in the women. The risk of hyperten-
sion and the risk of cholelithiasis were two to three
times as high among both men and women with a
body-mass index of 26, as compared with the leanest
group. With a body-mass index of 29 or higher, these
risks were greatly increased. Other conditions whose
incidence is increased by excess body fat are post-
menopausal breast cancer
 
24,25
 
; cancers of the endome-
trium, colon, and kidney
 
25
 
; stroke
 
26
 
; osteoarthritis
 
27
 
;
and infertility.
 
28
 
 Excess body fat appears to be protec-
tive against very few conditions: the incidence (but
not the associated mortality) of premenopausal breast
cancer is slightly lower among heavier women,
 
24
 
 and
the rates of hip fracture are inversely related to body
weight.
 
29
 
 Hip fractures contribute only slightly to to-
tal mortality rates, however.
 
Figure 1.
 
 Age-Specific Relation between Body-Mass Index and
the Risk of Death among Women (Panel A) and Men (Panel B)
45 to 75 Years of Age.
Data are from the American Cancer Society Cohort
 
17
 
 and June
Stevens, University of North Carolina.
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Figure 2.
 
 Relation between Body-Mass Index up to 30 and the
Relative Risk of Type 2 Diabetes, Hypertension, Coronary Heart
Disease, and Cholelithiasis.
Panel A shows these relations for women in the Nurses’ Health
Study, initially 30 to 55 years of age, who were followed for up
to 18 years.
 
18-21
 
 Panel B shows the same relations for men in the
Health Professionals Follow-up Study, initially 40 to 65 years of
age, who were followed for up to 10 years.
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ISSUES PERTAINING TO THE CREATION 
OF GUIDELINES FOR WEIGHT
 
The selection of a cutoff point on a continuum in-
volves the balancing of sensitivity and specificity. For
example, as shown in Figures 1 and 2, the risk of se-
rious conditions and death increases even at a body-
mass index of 23. Therefore, a maximally sensitive
guideline to identify persons at risk from excess body
fat would use an upper limit for body-mass index of
22 or 23. However, many persons would be consid-
ered to have false positive results according to this
criterion, because they would not subsequently have
the conditions associated with being overweight.
Conversely, if the upper limit were set at a body-
mass index of 27, many persons with a lower body-
mass index would not be classified as overweight but
would later have conditions that result from excess
body fat (false negative results). Balancing sensitivity
and specificity is difficult, because excess body fat is
clearly associated with multiple risks, but the costs
of being inappropriately labeled as overweight are dif-
ficult to quantify. Thus, weight guidelines inevitably
represent a somewhat arbitrary compromise. Since
the first Dietary Guidelines for Americans were
published in 1980, the language used to describe a
healthy weight and range of weights has varied slight-
ly.
 
1,10,30,31
 
 Throughout this period, the lower bound-
ary for body-mass index has been approximately 19,
and the upper boundary, with the exception of the
1990 guidelines, has been approximately 25.
In setting the 1995 guidelines for weight,
 
1
 
 the Di-
etary Guidelines Advisory Committee concluded that
mortality clearly increased significantly with a body-
mass index above 25,
 
16,17,32
 
 whereas the incidence of
diabetes, hypertension, and coronary heart disease be-
gan to increase well below a body-mass index of
25.
 
18-20,22,33
 
 Because of the importance of total mor-
tality, and because designating a cutoff point below
25 for the classification of overweight would label
more than 50 percent of U.S. adults overweight, the
committee concluded that a body-mass index of 25
represented a reasonable upper limit of healthy
weight. This cutoff point is consistent with that rec-
ommended by a steering committee of the American
Institute of Nutrition
 
33
 
 and an expert committee of
the World Health Organization.
 
34
 
 The International
Obesity Task Force provided a more detailed classi-
fication of values for the body-mass index: healthy
weight, 18.5 to 24.9; overweight, 25.0 to 29.9; class
I obesity, 30.0 to 34.9; class II obesity, 35 to 39.9;
and class III obesity, 40.0 or higher.
 
35
 
The cutoff point of 25 in the 1995 U.S. guidelines
for weight is well supported by data, but the lower
limit of 19 in the current recommendations (or 18.5
in the WHO guidelines) has far less empirical justi-
fication. The relatively few persons with a body-mass
index of 19 or lower in the United States include not
only healthy, active persons who have maintained a
low body-mass index for many years, but also heavy
smokers and those who have lost weight as a result
of illness.
 
36
 
 Morbidity and mortality among non-
smoking persons with stable body-mass indexes of
18 or lower, after the exclusion of those with recent
weight loss or ill health, have rarely been studied.
 
12
 
Among nonsmoking women in the Nurses’ Health
Study who had stable weights and had body-mass
indexes as low as 17, there was no excess mortality.
 
16
 
A point exists at which low body-mass index be-
comes a cause of ill health, but available data suggest
that using a body-mass index of 19 or lower to iden-
tify persons at risk for morbidity and mortality will
be highly nonspecific. Because of the lack of infor-
mation about body-mass indexes below the range of
healthy weight, the U.S. Dietary Guidelines Advisory
Committee decided not to label body-mass indexes
lower than 19 as healthy or unhealthy. However, as
clinicians have long known, a low body-mass index
resulting from unexplained weight loss demands a
thorough investigation for underlying causes.
 
37
 
WEIGHT GAIN WITH AGE
 
A major limitation of standard weight guidelines
is that a person initially at the low end of the range
can gain as much as 15 or 20 kg (33 or 44 lb) and
still remain within the recommended range. Much
smaller gains in weight during adulthood, however,
are associated with significantly increased risks of
many chronic diseases (Fig. 3). For example, as com-
pared with women and men in the Nurses’ Health
Study
 
18-21
 
 and the Health Professionals Follow-up
Study
 
22
 
 who maintained their weight within 2 kg
(4 lb) of their weight at 18 to 20 years of age, those
who gained 5.0 to 9.9 kg (11 to 22 lb) had risks of
coronary heart disease, hypertension, cholelithiasis,
and type 2 diabetes that were 1.5 to 3 times as high.
These increases in risk were greater with larger gains
in weight.
Changes in weight that have taken place since
young adulthood are useful for assessing risks asso-
ciated with body fat because they take into account
individual differences in frame size and lean mass
that are difficult to measure. In addition, change in
weight provides a single, readily interpretable num-
ber that is known, at least approximately, to most
persons. Most persons in the United States are not
overweight when growth ends, at about 18 years of
age for women and 20 years for men
 
11
 
; most excess
body fat accrues in the subsequent decades. Except
for the few persons involved in muscle building, sub-
stantial gains are largely fat. The absence of weight
gain, particularly among men older than 50, however,
does not indicate that fat has not increased. Beyond
this age, muscle mass is, to varying degrees, replaced
by fat, much of it within the abdomen. This phe-
nomenon may be manifested by an increasing waist
circumference.
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CONSIDERATIONS OF SEX AND AGE
 
Should weight guidelines differ for men and wom-
en? Should guidelines change with age? At identical
levels of body-mass index, women will, on average,
have more body fat.
 
38
 
 However, as shown in Figures
2 and 3, morbidity appears to increase with increasing
body-mass indexes in a similar fashion for men and
women, as does mortality.
 
17
 
 Small differences accord-
ing to sex may exist in these relations, but separate
guidelines do not appear to be justified.
The relation between age and body weight is com-
plex. For example, in the large American Cancer
Society cohort,
 
17
 
 the relation between body-mass in-
dex and total mortality or mortality from cardiovas-
cular causes was approximately linear for all age
groups up to 75 years, although the relative risks de-
clined with age (Fig. 1). That the relative risks de-
cline with age does not necessarily mean that excess
body fat becomes less serious in older persons. Be-
cause mortality rises dramatically with age, the ab-
solute excess risk associated with a higher body-mass
index increases rather than decreases with age. Fur-
thermore, because changes in body composition
with age may make body-mass index a less valid in-
dicator of body fatness in older people, the lower rel-
ative risks may reflect a lower validity of body-mass
index as a measure of body fat. In a cohort of men,
 
22
 
body-mass index was a strong predictor of coronary
heart disease among those younger than 65 but was
minimally predictive for older men. However, waist
circumference was weakly predictive of coronary dis-
ease among men younger than 65 but was strongly
predictive for older men, which suggests that body
fat is important at all ages but that the optimal means
of assessing fat changes with age.
 
CRITERIA FOR RECOMMENDATIONS
ON BODY CIRCUMFERENCE
 
In 1990, the Dietary Guidelines for Americans were
accompanied for the first time by recommendations
for the ratio of waist circumference to hip circumfer-
ence; the ratio was not to exceed 0.95 for men and
0.80 for women.
 
10
 
 In 1995, however, the guidelines
stated that concern was warranted if the ratio ex-
ceeded 1.0. Waist circumference and the ratio of
waist circumference to hip circumference are similarly
correlated with measures of risk factors for coronary
heart disease, such as high blood pressure or blood
lipid levels,
 
39
 
 and neither method has been consistent-
ly superior in predicting the risk of disease. Thus,
because of its greater simplicity, waist circumference
may be most useful in clinical practice.
As with the body-mass index, choosing a point on
the waist-circumference continuum as a guideline in-
volves a trade-off of sensitivity for specificity. For ex-
ample, an expert panel on overweight and obesity in
adults has recently suggested that increased risks exist
if waist circumference is greater than 102 cm (40 in.)
in men and 89 cm (35 in.) in women.
 
40
 
 With waist
circumferences smaller than these cutoff points, how-
ever, the relative risks of type 2 diabetes can be 3 to
5,
 
23,41
 
 which suggests that these limits are insensitive
to important degrees of abdominal adiposity. Han et
al. found that in men, a waist circumference of 94 to
102 cm (37 to 40 in.) was associated with a relative
risk of 2.2 of having one or more cardiovascular risk
 
Figure 3.
 
 Relation between the Change in Weight and the Rel-
ative Risk of Type 2 Diabetes, Hypertension, Coronary Heart
Disease, and Cholelithiasis.
Panel A shows these relations for change of weight from 18
years of age among women in the Nurses’ Health Study, initially
30 to 55 years of age, who were followed for up to 18 years.
 
18-21
 
Panel B shows the same relations for change of weight from 20
years of age among men in the Health Professionals Follow-up
Study, initially 40 to 65 years of age, who were followed for up
to 10 years.
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factors, and in women a circumference of 80 to 88
cm (32 to 35 in.) was associated with a relative risk
of 1.6.
 
39
 
 Ideally, guidelines for waist circumference
should be adjusted for overall body size, in particu-
lar for height, but this adds complexity with minimal
gains in predictiveness.
 
23
 
USING WEIGHT GUIDELINES
 
A primary use of weight guidelines is to provide
direction for healthy persons. Thus, periodic meas-
urements of height and weight are recommended for
all patients.
 
42
 
 Even small gains in weight within the
range of healthy weights can carry health risks, and
they indicate an imbalance between energy intake
and activity that portends larger increases in the fu-
ture. Thus, physicians should counsel their adult pa-
tients to make small but permanent adjustments in
physical activity and eating patterns if even a small
weight gain (e.g., 4 to 5 kg, or 10 lb) occurs after
adult height is attained or if they are approaching
the limit of the range for healthy weight. Attention
to increases in waist circumference by 5 cm (2 in.) or
more is also appropriate, even if weight has remained
stable or within the range of healthy weights. Past
weight guidelines have emphasized the development
of complications, such as hypertension or diabetes,
as additional indications for weight reduction. How-
ever, these conditions should be prevented by avoid-
ing weight gain and overweight, because conditions
such as diabetes and vascular complications may
not be reversible. Furthermore, these conditions may
make exercise and weight control more difficult.
For patients who are already overweight, weight
guidelines should not be used to define goals for
weight reduction, because for seriously overweight
persons the range of healthy weights is often practi-
cally unachievable. However, reductions of even 5 to
10 percent can substantially improve blood pressure,
serum lipid levels, and glucose tolerance
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 and reduce
the incidence of diabetes
 
19
 
 and hypertension.
 
20,40
 
Only limited data support the notion that inten-
tional weight loss will reduce total mortality rates,
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but this issue is particularly difficult to evaluate be-
cause intentional and disease-related weight losses are
difficult to distinguish. Nevertheless, the clear im-
provements in physiologic end points as well as the
reduced incidence of diabetes
 
19
 
 and hypertension
 
20
provide justification for weight loss as an objective.
Among women in the Nurses’ Health Study, those
who lost 11 kg (24 lb) or more had a risk of type
2 diabetes that was more than 75 percent lower than
that of nurses with unchanged weight.19 For most
overweight persons, the initial goal is to prevent fur-
ther weight gain and then to achieve moderate reduc-
tions in weight.
In summary, the rapidly rising prevalence of obe-
sity in the United States and most other countries will
add substantially to future morbidity and mortality
and will increase health costs. Preventing weight
gain and overweight among persons with healthy
weights and avoiding further weight gain among
those already overweight are important public health
goals. The road to prevention must begin with an in-
creased awareness of even small weight gains and the
counseling of patients to modify their diet and ac-
tivity patterns appropriately.
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